Putting magnetic resonance spectroscopy studies in context: Axonal damage and disability in multiple sclerosis

被引:142
作者
Matthews, PM
De Stefano, N
Narayanan, S
Francis, GS
Wolinsky, JS
Antel, JP
Arnold, DL
机构
[1] Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England
[2] Univ Siena, Inst Neurol Sci, Neurometab Unit, I-53100 Siena, Italy
[3] Montreal Neurol Hosp & Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada
[4] Univ Texas, Hlth Sci Ctr, Dept Neurol, Houston, TX 77225 USA
关键词
multiple sclerosis; magnetic resonance spectroscopy; axons; N-acetyl aspartate; MRI; disability;
D O I
10.1055/s-2008-1040884
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent magnetic resonance imaging (MRI) and magnetic resonance spectroscopic (MRS) techniques have focused the attention of the multiple sclerosis (MS) research community on reanalysis of classic pathological approaches that have suggested significant axonal injury in this demyelinating disease. There now is abundant evidence from animal work that substantial "innocent bystander" damage to axons can occur with central nervous system (CNS) inflammation. Given the close interactions between axons and glia, it is no surprise that glial damage leads to secondary axonal changes. MRI, MRS, and MRS imaging studies have emphasized that axonal loss or damage in MS can be both substantial and early. The dynamic observations that are allowed by these noninvasive measures of pathology have demonstrated direct correlations between these axonal changes and disability, making a compelling case for increased emphasis on finding treatments of MS that may limit damage to CNS axons or salvage injured axons.
引用
收藏
页码:327 / 336
页数:10
相关论文
共 49 条
[1]   PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF HUMAN BRAIN INVIVO IN THE EVALUATION OF MULTIPLE-SCLEROSIS - ASSESSMENT OF THE LOAD OF DISEASE [J].
ARNOLD, DL ;
MATTHEWS, PM ;
FRANCIS, G ;
ANTEL, J .
MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (01) :154-159
[2]   USE OF PROTON MAGNETIC-RESONANCE SPECTROSCOPY FOR MONITORING DISEASE PROGRESSION IN MULTIPLE-SCLEROSIS [J].
ARNOLD, DL ;
RIESS, GT ;
MATTHEWS, PM ;
FRANCIS, GS ;
COLLINS, DL ;
WOLFSON, C ;
ANTEL, JP .
ANNALS OF NEUROLOGY, 1994, 36 (01) :76-82
[3]   PROTON MAGNETIC-RESONANCE SPECTROSCOPIC IMAGING FOR METABOLIC CHARACTERIZATION OF DEMYELINATING PLAQUES [J].
ARNOLD, DL ;
MATTHEWS, PM ;
FRANCIS, GS ;
OCONNOR, J ;
ANTEL, JP .
ANNALS OF NEUROLOGY, 1992, 31 (03) :235-241
[4]  
ARNOLD DL, 1997, MAGNETIC RESONANCE S, P267
[5]   THE LONGSTANDING MS LESION - A QUANTITATIVE MRI AND ELECTRON-MICROSCOPIC STUDY [J].
BARNES, D ;
MUNRO, PMG ;
YOUL, BD ;
PRINEAS, JW ;
MCDONALD, WI .
BRAIN, 1991, 114 :1271-1280
[6]   Inhibition of N-acetylaspartate production: Implications for H-1 MRS studies in vivo [J].
Bates, TE ;
Strangward, M ;
Keelan, J ;
Davey, GP ;
Munro, PMG ;
Clark, JB .
NEUROREPORT, 1996, 7 (08) :1397-1400
[7]   PRELIMINARY STUDIES OF CYTOKINE-INDUCED FUNCTIONAL-EFFECTS ON THE VISUAL PATHWAYS IN THE RABBIT [J].
BROSNAN, CF ;
LITWAK, MS ;
SCHROEDER, CE ;
SELMAJ, K ;
RAINE, CS ;
AREZZO, JC .
JOURNAL OF NEUROIMMUNOLOGY, 1989, 25 (2-3) :227-239
[8]   MULTIPLE-SCLEROSIS IN CHILDREN - CEREBRAL METABOLIC ALTERATIONS MONITORED BY LOCALIZED PROTON MAGNETIC-RESONANCE SPECTROSCOPY INVIVO [J].
BRUHN, H ;
FRAHM, J ;
MERBOLDT, KD ;
HANICKE, W ;
HANEFELD, F ;
CHRISTEN, HJ ;
KRUSE, B ;
BAUER, HJ .
ANNALS OF NEUROLOGY, 1992, 32 (02) :140-150
[9]   Transgenic models to assess the pathogenic actions of cytokines in the central nervous system [J].
Campbell, IL ;
Stalder, AK ;
Chiang, CS ;
Bellinger, R ;
Heyser, CJ ;
Steffensen, S ;
Masliah, E ;
Powell, HC ;
Gold, LH ;
Henriksen, SJ ;
Siggins, GR .
MOLECULAR PSYCHIATRY, 1997, 2 (02) :125-129
[10]  
Charcot JM, 1868, GAZ HOP PARIS, V41, P554